Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Lexicon Pharmaceuticals (LXRX) over the last 16 years, with Dec 2024 value amounting to $13.5 million.

  • Lexicon Pharmaceuticals' Share-based Compensation rose 17.52% to $1.6 million in Q4 2012 from the same period last year, while for Dec 2012 it was $6.5 million, marking a year-over-year increase of 13.81%. This contributed to the annual value of $13.5 million for FY2024, which is 5.86% down from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its Share-based Compensation stood at $13.5 million for FY2024, which was down 5.86% from $14.3 million recorded in FY2023.
  • Lexicon Pharmaceuticals' Share-based Compensation's 5-year high stood at $14.3 million during FY2023, with a 5-year trough of $10.6 million in FY2021.
  • Moreover, its 3-year median value for Share-based Compensation was $13.5 million (2024), whereas its average is $13.1 million.
  • In the last 5 years, Lexicon Pharmaceuticals' Share-based Compensation decreased by 20.32% in 2021 and then grew by 24.48% in 2023.
  • Over the past 5 years, Lexicon Pharmaceuticals' Share-based Compensation (Yearly) stood at $13.3 million in 2020, then decreased by 20.32% to $10.6 million in 2021, then grew by 8.92% to $11.5 million in 2022, then rose by 24.48% to $14.3 million in 2023, then fell by 5.86% to $13.5 million in 2024.